India Faces Critical Shortage Of Two Vital Platinum Chemotherapy Drugs

Gist India is experiencing a critical nationwide shortage of two essential chemotherapy drugs, cisplatin and carboplatin, vital for treating various cancers. This scarcity is attributed to a sharp rise in global platinum prices, disruptions in West Asia shipping routes, and existing domestic price controls, leading to significant treatment delays and interruptions for cancer patients. Background Cisplatin and carboplatin are first and second-generation platinum compounds, respectively, widely used chemotherapeutic agents in India for treating solid tumours and certain blood cancers, including ovarian, head and neck, lung, breast, and testicular cancers. They are also crucial for childhood cancers like neuroblastoma and retinoblastoma, with limited effective alternatives. Key Pointers - The shortage rendered manufacturing financially unviable for generic drug makers due to increased raw material costs and fixed price caps. - Geopolitical conflicts and shipping constraints through West Asia have exacerbated the problem by restricting imports of platinum raw material. - While government hospitals in several states have largely stabilised supplies due to existing stocks and multiple procurement channels, private hospitals continue to face severe shortages. - The government temporarily increased ceiling rates…